Published by Josh White on 20th April 2026
(Sharecast News) - TheraCryf said on Monday that it has successfully manufactured clinical-grade material for its lead Ox-1 receptor antagonist, marking a key step towards initiating human trials.
URL: http://www.digitallook.com/dl/news/story/35864240/...